CIK: 0001907884 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value ($000): $727,068 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | NATERA INC | 2,900,000 | $141,114 | 19.4% | $49.51 | +3.0% | COM | 632307104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,600,000 | $88,218 | 12.1% | $33.07 | +1.9% | COM NEW | 15117B202 |
| ARGX | ARGENX SE | 184,300 | $71,827 | 9.9% | — | — | Put | 04016X101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,262,004 | $68,274 | 9.4% | $19.47 | +6.9% | COM | 87164F105 |
| PCVX | VAXCYTE INC | 1,300,000 | $64,922 | 8.9% | $31.97 | +48.3% | COM | 92243G108 |
| — | 2SEVENTY BIO INC | 4,890,706 | $49,494 | 6.8% | $10.18 | — | COMMON STOCK | 901384107 |
| VERA | VERA THERAPEUTICS INC | 3,000,000 | $48,150 | 6.6% | $12.39 | -27.1% | CL A | 92337R101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 975,298 | $26,938 | 3.7% | $14.02 | +78.5% | COM | 74366E102 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,454,730 | $22,345 | 3.1% | $22.63 | -19.6% | COM | 89422G107 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 2,848,197 | $20,051 | 2.8% | $8.59 | -6.5% | COM | 09058V103 |
| COGT | COGENT BIOSCIENCES INC | 1,617,391 | $19,150 | 2.6% | $10.32 | +11.1% | COM | 19240Q201 |
| — | BURNING ROCK BIOTECH LTD | 8,500,000 | $18,309 | 2.5% | $3.25 | — | SPONSORED ADS | 12233L107 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 709,498 | $16,879 | 2.3% | $20.32 | +26.3% | COM | 92790C104 |
| WVE | WAVE LIFE SCIENCES LTD | 3,924,602 | $14,286 | 2.0% | $4.31 | -6.4% | SHS | Y95308105 |
| — | AMARIN CORP PLC | 12,000,000 | $14,280 | 2.0% | $1.69 | — | SPONS ADR NEW | 023111206 |
| LQDA | LIQUIDIA CORPORATION | 1,642,244 | $12,892 | 1.8% | $4.44 | +74.9% | COM NEW | 53635D202 |
| OLMA | OLEMA PHARMACEUTICALS INC | 1,304,332 | $11,778 | 1.6% | $5.86 | +3.0% | COM | 68062P106 |
| — | SUTRO BIOPHARMA INC | 1,500,000 | $6,975 | 1.0% | $5.57 | — | COM | 869367102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 729,077 | $4,513 | 0.6% | $9.21 | — | SPONSORED ADS | 152309100 |
| PBYI | PUMA BIOTECHNOLOGY INC | 473,070 | $1,670 | 0.2% | $4.34 | -28.1% | COM | 74587V107 |
| — | FIBROGEN INC | 586,500 | $1,584 | 0.2% | — | — | Call | 31572Q808 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 92,602 | $1,527 | 0.2% | $25.11 | -28.1% | COM | 76243J105 |
| PTCT | PTC THERAPEUTICS INC | 28,500 | $1,159 | 0.2% | — | — | Call | 69366J200 |
| — | CONNECT BIOPHARMA HLDGS LTD | 535,005 | $603 | 0.1% | $1.53 | — | ADS | 207523101 |
| — | NEOLEUKIN THERAPEUTICS INC | 119,966 | $100 | 0.0% | $4.82 | — | COM | 64049K104 |
| — | CATALYST BIOSCIENCES INC | 89,886 | $32 | 0.0% | $0.91 | — | COM NEW | 14888D208 |